BioSpace News Archive

Two-Faced: How to Deal with the Backstabbing Coworkers

At some point in time, most life science professionals have face faced backstabbing coworkers. If you have faced one in your life, this article is right for you.

September 21, 2018
·
4 min read
·
Porschia Parker
Drug Development

Oxurion Enrolls First Patient in Phase 2 Clinical Study Evaluating THR-317 (anti-PlGF) for treatment of Idiopathic Macular Telangiectasia Type 1 (MacTel 1)

Oxurion NV announces that it has enrolled the first patient in a Phase 2 open-label multi-centre study evaluating the efficacy and safety of intravitreal THR-317

September 21, 2018
·
4 min read
Drug Development

Astellas Announces Positive Topline Results for Global Phase 3 Trial of Roxadustat in Chronic Kidney Disease (CKD) Patients with Anaemia not on Dialysis

Astellas Pharma Inc. today announced that roxadustat, an inhibitor of hypoxia inducible factor (HIF) prolyl hydroxylase activity, met its primary endpoints in the Phase 3 ALPS study

September 21, 2018
·
5 min read
Business

Medtech Company IME Medical Electrospinning Establishes New High-Tech Production Facility to Set The World Wide Standard for Ground Breaking Regenerative Medicine Solutions

Two new cleanrooms and a high-end laboratory enable the development and large scale production of electrospun scaffolds that meet the stringent requirements of the Medtech Regenerative Medicine Industry

September 21, 2018
·
6 min read
Business

VAXIMM Announces Regional Development and Commercialization Agreement with China Medical System Holdings

CMS gains exclusive rights to current VAXIMM pipeline and option for future programs for China and other Asian countries, ex-Japan

September 21, 2018
·
3 min read
Policy

Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders

License with Nationwide Children’s Hospital (NCH) through the Acquisition of Celenex (NCH Spinout)

September 21, 2018
·
9 min read
Business

Portola Pharmaceuticals Names Scott Garland President and Chief Executive Officer

Relypsa president and former Exelixis chief commercial officer brings significant commercial and operational expertise

September 21, 2018
·
5 min read
Business

TxCell announces first-half 2018 financial results and update on the proposed acquisition by Sangamo Therapeutics, Inc.

TxCell SA today announces financial results for the first half of 2018 and provides an update on the proposed acquisition by Sangamo Therapeutics, Inc.

September 21, 2018
·
9 min read
Policy

Going Its Own Way, European Regulators Reject Sarepta’s Exondys 51 for DMD

In September 2016, the U.S. FDA approved Sarepta Therapeutics’ eteplirsen, now marketed as Exondys 51, for Duchenne muscular dystrophy (DMD). And now, two years later, the European Medicines Agency (EMA) has rejected Sarepta’s application for Exondys 51.

September 21, 2018
·
3 min read
·
Mark Terry
Policy

Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems

Shares of Acadia Pharmaceuticals soared more than 26 percent in trading on Thursday and continue to climb this morning in premarket trading after the U.S. Food and Drug Administration affirmed the safety profile of the company’s lead drug, Nuplazid.

September 21, 2018
·
3 min read
·
Alex Keown